Analystreport

Bellicum Pharmaceuticals Inc (NASDAQ: BLCM) had its price target raised by analysts at Wells Fargo & Co from $4.00 to $18.00.

Bellicum Pharmaceuticals, Inc.  (BLCM) 
Last bellicum pharmaceuticals, inc. earnings: 3/12 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.bellicum.com/investor-overview